Leadless pacemakers — such as the Aveir VR (Abbott) and Micra AV/VR (Medtronic) — represent a major advance in device therapy, eliminating transvenous leads and their associated complications. However, a critical and underappreciated limitation remains: they pace from the right ventricle (RV), creating the same electromechanical disruption responsible for pacing-induced cardiomyopathy (PICM) in traditional RV lead systems.
The reduction in ejection fraction associated with leadless pacemakers is not caused by the absence of a lead — it is caused by the site and mode of ventricular activation, which bypasses the native His-Purkinje conduction system and generates pathological dyssynchrony.
1. Ventricular Dyssynchrony: The Root Cause
The native conduction system activates the ventricles in a precisely orchestrated sequence via the His bundle, left and right bundle branches, and Purkinje fibers — producing near-simultaneous depolarization of both ventricles in approximately 80–120 ms.
When a leadless pacemaker fires from the RV apex or mid-septum, the impulse must propagate through slow myocyte-to-myocyte conduction rather than the Purkinje network. This results in:
- A left bundle branch block (LBBB)-like ECG pattern
- Delayed lateral wall activation — the LV free wall contracts 80–130 ms after the septum
- Interventricular dyssynchrony — RV contracts before LV
- Septal dyskinesis ("septal bounce") — early septal motion without productive ejection
This discoordination reduces the mechanical efficiency of systole, impairs diastolic filling, and elevates wall stress — all contributing to a lower ejection fraction.
Interventricular Dyssynchrony
RV contracts before LV, causing paradoxical septal motion and reduced net forward output during systole.
Intraventricular Dyssynchrony
Delayed lateral wall activation causes asynchronous LV contraction, reducing ejection efficiency and increasing wall stress.
Diastolic Impairment
Abnormal relaxation sequence leads to elevated LV filling pressures, reduced diastolic reserve, and functional mitral regurgitation.
Increased Myocardial O₂ Demand
Inefficient contraction requires greater energy expenditure per unit of cardiac output, accelerating maladaptive remodeling over time.
2. Pacing-Induced Cardiomyopathy (PICM)
When high RV pacing burden (typically >20–40%) persists over months to years, cumulative dyssynchrony triggers a cascade of maladaptive structural changes known collectively as pacing-induced cardiomyopathy (PICM):
Eccentric LV Hypertrophy and Dilation
Abnormal wall stress redistribution promotes volume overload remodeling — sarcomere addition in series — leading to progressive LV enlargement and spherical geometry, which further impairs contractile function.
Mitral Regurgitation
Papillary muscle dyssynchrony, annular dilation, and elevated LV filling pressures combine to produce secondary mitral regurgitation, creating an additional volume load that accelerates EF decline.
Neurohormonal Activation
Reduced cardiac output activates the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system, driving further remodeling, fibrosis, and cardiomyocyte hypertrophy in a self-perpetuating cycle.
Patients with complete heart block who require near-100% ventricular pacing face the highest lifetime risk of PICM — a critical consideration when selecting pacing strategy.
ABC Farma — Cardiac Electrophysiology Series
3. Cellular and Molecular Mechanisms
Beyond macroscopic remodeling, chronic dyssynchronous pacing disrupts myocardial biology at the cellular level:
Abnormal Calcium Handling
Heterogeneous mechanical loading produces regional differences in calcium transient amplitude and kinetics. SERCA2a (sarco/endoplasmic reticulum Ca²⁺-ATPase) is downregulated in early-activated regions, reducing calcium uptake efficiency and impairing contractile reserve.
Myosin Heavy Chain Isoform Shift
Chronic pressure and volume overload shifts the ventricular myosin heavy chain isoform profile from alpha-MHC (fast, efficient) toward beta-MHC (slow, less efficient), reducing intrinsic contractility independent of loading conditions.
Regional Fibrosis
Late-activated regions (typically the lateral LV wall) bear disproportionate mechanical stress during systole. This promotes interstitial fibrosis, reducing compliance and propagating electrical heterogeneity that further worsens dyssynchrony.
4. Risk Factors for EF Reduction
Not all patients develop significant EF decline with RV pacing. The following factors increase PICM risk:
| Risk Factor | Impact | Risk Level |
|---|---|---|
| Pacing burden >40% | High cumulative dyssynchrony exposure | High |
| Complete heart block (100% pacing) | No native conduction escape | High |
| Pre-existing LV dysfunction (EF <50%) | Reduced contractile reserve | High |
| Wide paced QRS (>160 ms) | Greater dyssynchrony magnitude | High |
| Female sex | Greater PICM susceptibility (unclear mechanism) | Moderate |
| Pacing burden <20% | Minimal cumulative dyssynchrony | Low |
5. Does "Leadless" Change the Risk?
A common misconception is that the absence of a transvenous lead confers electromechanical benefit. It does not. The advantages of leadless systems are real and important — but they relate to mechanical and infectious complications, not pacing physiology:
Key Point: Both Aveir VR and Micra devices pace from the RV, generating an LBBB-like activation pattern functionally identical to traditional RV apical or septal lead pacing. Leadless design does not prevent pacing-induced cardiomyopathy.
6. The Solution: Physiological Pacing
The logical response to PICM risk is to restore physiological ventricular activation. Two strategies have emerged as clinically validated alternatives:
His Bundle Pacing (HBP)
Direct capture of the His bundle activates the native Purkinje network, producing narrow QRS complexes and synchronous biventricular activation. Technical challenges (higher thresholds, risk of loss of capture) limit widespread adoption.
Left Bundle Branch Area Pacing (LBBAP)
LBBAP has emerged as the preferred physiological pacing strategy. By deploying a deep septal lead to capture the left bundle branch or its arborization — or to pace the LV conduction system directly via the septal myocardium — LBBAP achieves:
- Narrow paced QRS with physiological activation pattern
- Preserved or improved LVEF versus RV pacing
- Lower pacing thresholds than HBP with greater stability
- Correction of pre-existing LBBB in selected patients
For patients with complete heart block requiring near-100% pacing, LBBAP is the electrophysiologically rational strategy to prevent PICM. Periodic echocardiographic monitoring of LVEF remains mandatory for all high-burden RV-paced patients, including those with leadless devices.
Summary
Leadless pacemakers reduce ejection fraction through the same fundamental mechanism as all RV pacing systems: disruption of the native His-Purkinje conduction sequence, generating ventricular dyssynchrony. Over time, this dyssynchrony drives structural remodeling, mitral regurgitation, neurohormonal activation, and cellular dysfunction — collectively constituting pacing-induced cardiomyopathy.
The innovation of leadless technology addresses lead-related complications but does not solve the fundamental electromechanical problem of RV pacing. Physiological pacing strategies — particularly LBBAP — represent the evolving standard of care for patients with high pacing burden.